News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva In-Focus: A Webinar Series For The Investment Community Focusing On Teva Pharmaceutical Industries Limited (TEVA)’s R&D Activities



12/4/2013 7:30:01 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that 15 new projects have entered its development pipeline from its New Therapeutic Entities (NTE) program.

Launched one year ago, the NTE program has delivered new pipeline assets in major therapeutic areas, including:

•Innovation in the abuse deterrent delivery of opioids for pain

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES